- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical implications of high NQO1 expression in breast cancers
Authors
Keywords
Breast cancer, NQO1, Immunohistochemistry, Prognosis
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 33, Issue 1, Pages 14
Publisher
Springer Nature
Online
2014-02-06
DOI
10.1186/1756-9966-33-14
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- NAD(P)H: Quinone Oxidoreductase 1 (NQO1) C609T Gene Polymorphism Association with Digestive Tract Cancer: A Meta-analysis
- (2013) Cheng-Lin Zhu et al. Asian Pacific Journal of Cancer Prevention
- High expression of ezrin predicts poor prognosis in uterine cervical cancer
- (2013) Jienan Kong et al. BMC CANCER
- NQO1 C609T polymorphism correlated to colon cancer risk in farmers from western region of Inner Mongolia
- (2013) Xiu-Lan Su et al. Chinese Journal of Cancer Research
- Catalase Abrogates -Lapachone-Induced PARP1 Hyperactivation-Directed Programmed Necrosis in NQO1-Positive Breast Cancers
- (2013) E. A. Bey et al. MOLECULAR CANCER THERAPEUTICS
- Interplay of Stem Cell Characteristics, EMT, and Microtentacles in Circulating Breast Tumor Cells
- (2013) Monica Charpentier et al. Cancers
- The role of targeted therapy and biomarkers in breast cancer treatment
- (2012) Alison T. Stopeck et al. CLINICAL & EXPERIMENTAL METASTASIS
- Ezrin overexpression predicts the poor prognosis of gastric adenocarcinoma
- (2012) Jingchun Jin et al. Diagnostic Pathology
- The Oncoprotein HBXIP Uses Two Pathways to Up-regulate S100A4 in Promotion of Growth and Migration of Breast Cancer Cells
- (2012) Shuangping Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Genetic polymorphisms of NQO1, CYP1A1 and TPMT and susceptibility to acute lymphoblastic leukemia in a Tunisian population
- (2012) Slah Ouerhani et al. MOLECULAR BIOLOGY REPORTS
- NAD(P)H:quinone oxidoreductase 1 (NQO1) in the sensitivity and resistance to antitumor quinones
- (2011) David Siegel et al. BIOCHEMICAL PHARMACOLOGY
- Evaluation of HER2 and p53 expression in predicting response to docetaxel-based first-line chemotherapy in advanced breast cancer
- (2011) Andrea Camerini et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Magnitude of risks and benefits of the addition of bevacizumab to chemotherapy for advanced breast cancer patients: Meta-regression analysis of randomized trials
- (2011) Federica Cuppone et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Two minor NQO1 and NQO2 alleles predict poor response of breast cancer patients to adjuvant doxorubicin and cyclophosphamide therapy
- (2011) David Jamieson et al. Pharmacogenetics and Genomics
- The NAD(P)H:Quinone Oxidoreductase 1 induces cell cycle progression and proliferation of melanoma cells
- (2010) Marco Garate et al. FREE RADICAL BIOLOGY AND MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started